Questions and Flowcharts
Fig. 1 ADK ductal adenocarcinoma No: small NFET or other benign solid lesion (?) B-mode: Hypoechoic: ADK or NFET Hyperechoic: focal fat accumulation (?) CEUS Hypoenhancing: ADK (→CT) Hypervascular: NET…
Fig. 1 ADK ductal adenocarcinoma No: small NFET or other benign solid lesion (?) B-mode: Hypoechoic: ADK or NFET Hyperechoic: focal fat accumulation (?) CEUS Hypoenhancing: ADK (→CT) Hypervascular: NET…
© Springer-Verlag Italia 2015Mirko D’Onofrio, Paola Capelli and Paolo Pederzoli (eds.)Imaging and Pathology of Pancreatic Neoplasms10.1007/978-88-470-5678-7_10 Imaging Stigmata Review and Interpretation Anna Gallotti1 , Francesco Alessandrino1 and Fabrizio Calliada1 (1) Department of Radiology, San Matteo University Hospital, Viale Camillo…
Disease site Presentation Recommended treatment Pancreas Resectable Surgery +/− adjuvant chemoradiotherapy or chemotherapy Borderline resectable (adequate KPS) Neoadjuvant chemoradiation followed by restaging and resection if feasible Borderline resectable (poor KPS)…
, Albert J. Chang1, Alexander R. Gottschalk1 and Mack RoachIII2 (1) Department of Radiation Oncology, University of California San Francisco, 1600 Divisadero Street, Suite H1031, San Francisco, CA, USA (2) Department of Radiation Oncology and…
Study Year Number of patients Primary site Treated site Dose Local control Overall survival Toxicity Casamassima 2012 48 Multiple Adrenal Most common 36 Gy/3 fractions 90 % (2 years) 40…
Disease site Presentation Recommended treatment Extremity Early stage (I) Surgery->EBRT for +/close margin Intermediate-advanced stage (II–III) Surgery->post-op EBRT or pre-op EBRT->surgery, ±chemo for deep/high grade tumors Retroperi-toneal Resectable Surgery + IORT- >post-op…
Presentation Treatment recommendations Isolated lateral pelvic recurrences Resection, palliative EBRT, SBRT, or systemic therapy Isolated nodal recurrence Resection, EBRT ± SBRT, SBRT alone, or systemic therapy Oligometastatic disease Resection, SBRT, or…
(2.1) In its simplest form, differences in tissue or tumor responses can be calculated using BED, the biologically effective dose, obtained from a fraction size of dose d delivered n…